Atlas Trials

Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT05683249 · COMPLETED

Trial details

NCT number
NCT05683249
Sponsor
Neurocentria, Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
ADHD
Start date
2023-02-25
Primary completion
2024-01-17
Enrollment
223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.